A Randomized, Double-blind, Double-dummy, Placebo-controlled, 3x4 Factorial Design Trial to Evaluate Telmisartan 20 and 80 mg Tablets in Combination With Ramipril 1.25, 10, and 20 mg Capsules After Eight Weeks of Treatment in Patients With Stage I or II Hypertension, With an ABPM Sub-study
A Randomized, Double-blind, Double-dummy, Placebo-controlled, 3x4 Factorial Design Trial to Evaluate Telmisartan 20 and 80 mg Tablets in Combination With Ramipril 1.25, 10, and 20 mg Capsules After Eight Weeks of Treatment in Patients With Stage I or II Hypertension, With an ABPM Sub-study
To identify dose combinations of telmisartan and ramipril that are more effective in reducing diastolic blood pressure than each of the respective monotherapies in patients with Stage I or II hypertension.
Inclusion Criteria:
Exclusion Criteria:
Jeffersonville, Indiana, United States
Capital Federal, Argentina
Capital Federal, Argentina
CordobaCordoba, Argentina
Puente Alto, Santiago de Chile, Chile
Acapulco Guerrero, Mexico
Col Ciudad de Sol Zapopan, Mexico
Col. Magdalena de Las Salinas, Mexico
México D.F, Mexico
Bella Vista, Callao,, Peru